NEVVI Medicare utilization intelligence

← back

AGHELI, AREFMD NPI 1710204573 Clinician

Hematology-Oncology · EAST SYRACUSE, NY

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 33 years since medical school (class of 1993, self-reported to CMS)
Location EAST SYRACUSE, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 89 codes billed · 94,375 disclosed services (CY2024 — most recent year in data)
Current groups
member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Group affiliation since 2019

20192026
CHAMPLAIN VALLEY PHYSICIANS HOSPITAL MEDICAL CENTER
2025–2026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2024–2026
HEMATOLOGY-ONCOLOGY ASSOCIATES OF CNY, PC
2019–2024

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2018-08

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J1756 Injection, iron sucrose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
84100 Phosphate level
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83735 Magnesium level
83615 Lactate dehydrogenase (enzyme) level
84550 Uric acid level, blood
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
82784 Gammaglobulin (immune system protein) measurement
J0640 Injection, leucovorin calcium, per 50 mg
96375 Injection of additional new drug or substance into vein
96372 Injection of drug or substance under skin or into muscle
J9190 Injection, fluorouracil, 500 mg
82607 Cyanocobalamin (vitamin b-12) level
83521 Measurement of immunoglobulin light chains
J9045 Injection, carboplatin, 50 mg
85044 Red blood count, manual test
82746 Folic acid level, serum
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96413 Administration of chemotherapy into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
84443 Blood test, thyroid stimulating hormone (tsh)
J2405 Injection, ondansetron hydrochloride, per 1 mg
96361 Infusion into a vein for hydration, each additional hour
84165 Protein measurement, serum
96374 Injection of drug or substance into vein
86334 Immunologic analysis technique on serum (immunofixation)
J1200 Injection, diphenhydramine hcl, up to 50 mg
J3475 Injection, magnesium sulfate, per 500 mg
85610 Blood test, clotting time
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
82378 Carcinoembryonic antigen (cea) protein level
88184 Flow cytometry technique for dna or cell analysis, first marker
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J7050 Infusion, normal saline solution, 250 cc
96360 Infusion into a vein for hydration, 31-60 minutes
82668 Erythropoietin (protein) level
83010 Haptoglobin (serum protein) level
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
96415 Administration of chemotherapy into vein, each additional hour
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82533 Cortisol (hormone) measurement, total
82248 Bilirubin level, direct
84439 Thyroxine (thyroid chemical), free
82306 Vitamin d-3 level
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
81002 Urinalysis, manual test
86146 Beta 2 glycoprotein 1 antibody (autoantibody) measurement
86147 Cardiolipin antibody (tissue antibody) measurement
99195 Drawing of blood for a medical problem
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
96411 Administration of additional new drug or substance into vein using push technique
J7030 Infusion, normal saline solution , 1000 cc
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
80074 Acute hepatitis panel
84153 Psa (prostate specific antigen) measurement, total
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
82232 Beta-2 microglobulin (protein) level
83036 Hemoglobin a1c level
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
84403 Testosterone (hormone) level, total
86038 Screening test for autoimmune disorder
84436 Thyroxine (thyroid chemical), total
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
80047 Blood test, basic group of blood chemicals (calcium, ionized)
85014 Red blood cell concentration measurement
85730 Coagulation assessment blood test, plasma or whole blood
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
G0452 Molecular pathology procedure; physician interpretation and report
83090 Homocysteine (amino acid) level
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.